| 1 Persistent bacteriuria at 48 hours |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
| 2 Treatment failure after 48 hours of therapy |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
| 3 Recurrent UTI within 1 month |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
| 4 Adverse events |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
| 4.1 Total adverse events |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
| 4.2 Gastrointestinal adverse events |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |